Tag Archives: business development

Professional Development Opportunities at BIO 2015

ExecTraining_115x76_

BIO offers two executive training courses to help attendees grow professionally, both co-located at the 2015 BIO International Convention in Philadelphia, PA from June 13-15, 2015. The Business Development Fundamentals and Advanced Business Development courses support the activity that takes place at our partnering and investor conferences each year by training individuals who are making the deals that drive this industry. Each course is taught by experienced business development professionals from leading pharmaceutical and biotechnology Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,

PTO Patent Examinations in the wake of Mayo and Myriad

stopped-media-115x76

Biotech patent applicants are finding themselves in uncharted waters.   After the Supreme Court’s decisions in Mayo Collaborative Svs. v. Prometheus Labs and Ass’n for Molecular Pathology v. Myriad Genetics, companies have been trying to understand how these decisions will impact the industry. A recent study supported by BIO, in collaboration with Bloomberg BNA and the law firm of Robins, Kaplan, Miller & Ciresi analyzed how Mayo and Myriad have changed patent eligibility for biotechnology. Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , , , , , , , , ,

The Most Linked In Man in Biotech Retires after 35 Years

Chris Y

The biotech world loses one of its preeminent titans of business development this year with the retirement of Chris Yochim. Variously dubbed “the face of AstraZeneca”, “Mr. Conference”, and other monikers as colorful as his dress shirts, Chris concludes a career spanning 35 years in the pharmaceutical industry. Trained as a pharmacologist, he contributed to the identification of several candidate compounds that are marketed drugs today, but more than anything else, Chris is known as Read More >

Events  |  1 Comment  |  Email This Post
Tags: , , , , , , , ,

GEN’s “Top 10” Session Picks for the 2014 BIO International Convention

John Sterling

The following article, reproduced in full below, was originally published at Genetic Engineering & Biotechnology News. It’s been a “hot” year for biotech! As G. Steven Burrill, CEO of Burrill & Co., noted in a recent report, life science firms raised $2.9 billion in new equity capital globally from public investors in February. This included $1.1 billion raised by 18 companies that completed initial public offerings and $1.8 billion raised by 23 companies that completed Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , ,

Vote in the 2014 Buzz of BIO Contest!

Buzz-of-BIO

The BIO International Convention is all about raising your profile, making connections, and moving your business forward. One of the more creative and fun ways for companies to accomplish these goals is the annual Buzz of BIO contest. This is an online voting contest for the industry to cast their pick for this year’s most creative biotech company. Prizes This year, there are two categories: Pipelines of Promise, and Technologies of Tomorrow. One company from each of Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,